10:08 AM
This story features Respiri Ltd Fully Paid Ord. Shrs, and other companies. For more info SHARE ANALYSIS: RSH
Last year s pandemic put the focus firmly on telehealth services providers, but share prices have deflated since as investors started asking questions, and on the general realisation telehealth has its limits too.
-Covid-19 triggered a rush into telehealth services and service providers in 2020
-Share market enthusiasm triggered a number of fresh telehealth IPOs
-Large cap companies ResMed and Cochlear among key beneficiaries
By Nikhil Gangaram
Nearly three decades ago, it took approximately 13 years to sequence the human genome. Today, the latest technology can have it done in just under an hour. The mind boggles to think how far and fast modern medicine has progressed and what it will look like in the future.
কোভিড টিকা: বিশ্ব যখন সঙ্কটে, যুক্তরাষ্ট্র বসে আছে মজুদ নিয়ে bdnews24.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bdnews24.com Daily Mail and Mail on Sunday newspapers.
TODAY’S reports from the People’s Covid Inquiry make harrowing reading.
A consultant in emergency medicine describes hospital staff having to research their own procedures during the first wave and, by the second, being exhausted and demoralised.
A train driver details the consequences of the government’s panic closure of 40 London Underground stations and a bus driver the lack of any PPE until five months into the outbreak, while a university professor in occupational health documents PPE supplies lying undelivered at the docks.
Each story explains why, for much of the past year, our country, supposedly with a developed economy and a publicly run health service, has suffered one of the highest death rates in the world: 127,000 people so far.
The N95 Mask Shortage is a Myth: Here’s Why
The N95 Mask Shortage is a Myth: Here’s Why
April 14, 2021
N95s, highly-protective masks that filter out at least 95 percent of airborne viral particles, are some of the most coveted products in the world. One year into the global COVID-19 pandemic, their allocation has been bungled in nearly every way possible.
As the months have gone by, the number of available N95s has soared, and yet the US government has neither publicized the new mask companies nor directed the increasing supplies to where they are most needed. A lack of knowledge and trust in these companies has led hospitals to severely ration their workers’ N95s rather than purchase additional supplies. The private market is no better: Facebook, Amazon, and Google are largely blocking domestic N95 manufacturers from advertising and selling their products. At the same time, most consumers feel obliged to use less-protective cloth or surgical masks due to continuing CDC g
HEALTH CARE BRIEFING: Drug Pricing Leads Congress Health Agenda bgov.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bgov.com Daily Mail and Mail on Sunday newspapers.